Phase
Condition
Chronic Pelvic Pain
Interstitial Cystitis
Dysmenorrhea (Painful Periods)
Treatment
Sacral neuromodulation
Clinical Study ID
Ages 22-70 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for theduration of the study
Female, aged 22-70
Chronic pelvic pain (= pain below umbilicus) score of 4 or greater on 10-point VAS,present for 6 months or greater (screening patient)
Failed at least 1 or more conservative treatments (e.g. pelvic floor physicaltherapy, biofeedback, behavioral modification, oral pharmacotherapy, bladderinstillations)
No changes to current regimen of medications for their pelvic pain for > 4 weeksprior to screening
For females of reproductive potential: use of highly effective contraception (e.g.licensed hormonal or barrier methods), for at least 1 month prior to screening andagreement to use such a method during study participation
Participant agrees not to start any new treatment interventions for CPP prior toVisit 4 (Primary Endpoint)
Exclusion
Exclusion Criteria:
History of any active pelvic cancer
Any significant medical condition that is likely to interfere with study procedures,device operation, or likely to confound evaluation of study endpoints
Concurrent pain management strategies within the past 3 months that may interfere ormask study intervention (e.g. pelvic floor physical therapy, shockwave therapy,trigger point injections, bladder instillations)
Any psychiatric or personality disorder at the discretion of the study physician.This does not include depression or generalized anxiety disorders that are stable.
Current symptomatic urinary tract infection (UTI) or more than 6 UTIs in past year
Severe or uncontrolled diabetes (A1C > 7, documented in the last 3 months) ordiabetes with peripheral nerve involvement
Interstitial cystitis diagnosis with Hunner's lesions as this is a severeinflammatory bladder condition that can only be treated with eradication of thelesions or a cystectomy. SNM would be be expected to help for IC with Hunner'slesions
Previously implanted with a sacral neuromodulation device or participated in asacral neuromodulation trial
Subject with documented history of allergy to titanium, zirconia, polyurethane,epoxy, or silicone
Implantation of spinal cord stimulator and/or drug delivery pumps, whether turned onor off
A female who is breastfeeding or of child-bearing potential with a positive urinepregnancy test or not using adequate contraception
Current treatment for active malignancy (skin cancers excluded)
Patients with spinal pathology that could confound study results. This may includeparticipants with cauda equina syndrome, spinal stenosis, neurogenic claudication,lumbar radiculopathy, patients with primary complaints of leg pain with numbness andor weakness, patients with a primary pain compliant that is vascular in origin,clinical evidence of progressive neurologic pathology, mechanical instability orother spinal pathology that requires surgical intervention, spine or visceral painsecondary to neoplasm, visceral pain in the upper abdomen rather than the pelvis,current diagnosis of fibromyalgia participants with significant cognitiveimpairment, participants with a condition currently requiring or likely to requireuse of diathermy or MRI or history of any other condition that in the opinion of theinvestigator could put the participant at risk or interfere with study resultsinterpretation. (screening patient).
Participants involved in ongoing litigation and or injury claims or workerscompensation claims.
Participation in a current clinical trial or within the preceding 30 days
Note- to preserve the scientific integrity of the study some criteria have been omitted from this posting. All eligibility criteria will be listed at the close of the study.
Study Design
Study Description
Connect with a study center
Beaumont Hospital-Royal Oak
Royal Oak, Michigan 48073
United StatesSite Not Available
Corewell Health William Beaumont University Hospital
Royal Oak, Michigan 48073
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.